2026-03-02 14:59 |
Detailed record - Similar records
|
2026-03-02 14:57 |
Detailed record - Similar records
|
2026-03-02 11:10 |
Detailed record - Similar records
|
2026-03-02 10:09 |
[DZNE-2026-00230]
Contribution to a conference proceedings/Contribution to a book
Schmitz, L. ; Plack, M. ; Koyak, B. ; et al
Towards Automated Analysis of Gaze Behavior from Consumer VR Devices for Neurological Diagnosis
2025Biocomputing 2026 : [Proceedings] - WORLD SCIENTIFIC, 2025. - ISBN 978-981-98-2474-8978-981-98-2475-5 - doi:10.1142/9789819824755_0016 Pacific Symposium on Biocomputing 2026, Kohala CoastKohala Coast, Hawaii, 3 Jan 2026 - 7 Jan 20262026-01-032026-01-07
WORLD SCIENTIFIC 219-235 (2025) [10.1142/9789819824755_0016]2025
Recent studies have demonstrated that eye tracking is a valuable tool in the detection, classification and staging of neurodegenerative diseases such as Parkinson's Disease (PD). However, traditional methods for capturing gaze data often rely on expensive and non-engaging clinical equipment such as video-oculography, limiting their accessibility and scalability. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-03-02 10:03 |
Detailed record - Similar records
|
2026-02-26 16:41 |
Detailed record - Similar records
|
2026-02-26 16:28 |
Detailed record - Similar records
|
2026-02-26 11:51 |
[DZNE-2026-00226]
Journal Article
Grover, S. ; Gockel, I. ; Latiano, A. ; et al
First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia.
Idiopathic achalasia (IA) is characterised by the degeneration of neurons in the myenteric plexus leading to an irreversible impaired oesophageal function. Although immune-mediated mechanisms have been proposed, the underlying aetiopathology of IA remains poorly understood.This study aimed to uncover the genetic risk architecture of IA.We carried out the first genome-wide association study (GWAS) on 4602 European patients with IA and 10 766 ethnically-matched controls.A single nucleotide polymorphism (SNP) in HLA-DQB1 leading to an 8-amino acid insertion on the protein level conferred strongest IA risk (PQGPPPAG: p=3.27×10-68, OR=2.45). [...]
Detailed record - Similar records
|
2026-02-26 11:48 |
[DZNE-2026-00225]
Journal Article
Eckenweber, S. ; Völter, F. ; Franzmeier, N. ; et al
Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.
Recent studies demonstrated strong agreement between early-phase β-amyloid-PET perfusion imaging and glucose hypometabolism assessed by [18F]FDG-PET, indicating the potential of early-phase β-amyloid-PET as a surrogate biomarker of neuronal injury. We therefore aimed to investigate the additive value of early-phase β-amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia syndromes in clinical routine.[18F]florbetaben- and [18F]flutemetamol-PET scans (n = 379) performed between July 2013 and July 2021 were analyzed for their amyloid status and the presence of a neurodegenerative hypoperfusion pattern using visual assessment and z-score maps. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-02-26 11:44 |
Detailed record - Similar records
|
|
|